On this week’s Underreported, Foreign Policy’s Joshua Keating discusses “The Stories You Missed in 2011,” including India’s military buildup and the shrinking supply of camel meat in Saudi Arabia.
Guests:
Joshua Keating
About The Leonard Lopate Show
Host Leonard Lopate lets you in on the best conversations with writers, actors, ex-presidents, dancers, scientists, comedians, historians, grammarians, curators, filmmakers, and do-it-yourself experts.
Hosted by Leonard Lopate
Sign up for the Book Club e-newsletter.
Links
- 2012 Election Coverage
- 25 Years of Lopate
- American History XX
- Backstory
- Globavores: Food Travels Around The World Since 1492
- Guest Hosts
- Guest Picks
- Please Explain
- The Gurus of How-To
- The Leonard Lopate Show Book Club
- The Lodown
- The Story of New York in 10 Objects
- The Word Maven: Patricia T. O'Conner
- Tributes
- Underappreciated
- Underreported
- Web Extras
Show Archive
Show Archive
Comments [1]
Geron Corp. is exiting the field it pioneered in a calculated business move that underscores the long, costly path embryonic stem cells face to become real-world products.
Late Monday, the company said it would halt its study of a stem cell-based treatment for spinal cord injury, the first embryonic stem cell trial approved in the U.S.
The Menlo Park, Calif., company had long been viewed as the undisputed leader in stem cell therapies.
Leave a Comment
Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.